MusclePharm Corporation
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Ryan Charles Drexler
- Full Time Employees
- 21
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Address
- 4400 Vanowen Street Burbank CA United States of America 89119
- IPO Date
- Apr 27, 2010
- CIK
- 0001415684
- Website
- musclepharm.com
- Similar Companies
- Business
- MusclePharm Corporation is a sports nutrition company specializing in the development, manufacturing, and sale of nutritional supplements designed to support active lifestyles and athletic performance. Its product portfolio includes protein powders such as Combat Protein Powder and Combat 100% Whey; protein bars including Combat Ready Protein Bars; essential supplements like BCAA (branched-chain amino acids), creatine powders, Z-PM capsules, and other performance-enhancing supplements. The company also offers energy beverages, notably the Fitmiss Energy drink. MusclePharm targets athletes and fitness enthusiasts, offering scientifically formulated products to support muscle growth, recovery, and overall physical performance. Founded in 2007, MusclePharm is headquartered in Denver, Colorado, and operates primarily in the United States with distribution channels spanning wholesale, retail, and online platforms. In October 2023, MusclePharm underwent a major strategic change when it was acquired by FitLife Brands, a Nebraska-based company focused on supplement brand aggregation. This acquisition included substantially all of MusclePharm’s assets and aimed to leverage MusclePharm’s strong brand presence in sports nutrition. Post-acquisition, FitLife Brands has emphasized expanding MusclePharm’s online direct-to-consumer sales and broadening wholesale distribution channels. Recent company initiatives include the launch of new product lines such as the Fitmiss Energy beverage and strategic partnerships to enhance market reach, including collaborations with major retailers like Walgreens and Amazon. FitLife’s acquisition and integration of MusclePharm, combined with other recent acquisitions such as Mimi’s Rock Corp, are part of its effort to boost top-line revenue and profitability in the competitive sports nutrition sector. MusclePharm serves the health, sports nutrition, and weight management industries with a comprehensive range of products focused on performance, recovery, and overall health. The company’s products are scientifically driven and marketed under the MusclePharm brand, which is recognized for quality and innovation in protein supplements, amino acids, and related nutritional products. MusclePharm’s offerings cater primarily to athletes, fitness professionals, and health-conscious consumers seeking clinically supported dietary supplements. Under FitLife Brands’ ownership, MusclePharm benefits from expanded resources and a strategic focus on digital sales channels aimed at revitalizing growth and market share in a crowded and evolving sector. MusclePharm’s notable recent business developments also include a private placement of $2.5 million in senior secured notes and SEC filings for a planned IPO uplisting to Nasdaq, evidencing efforts for financial restructuring and capitalizing on growth opportunities. The company’s integration within FitLife Brands’ portfolio supports synergistic growth alongside other nutrition brands, reinforcing its market position in the active lifestyle segment. Overall, MusclePharm is a scientifically driven sports nutrition company offering a diversified, clinically supported product line in protein supplements, amino acids, and energy drinks, operating chiefly in the U.S. and managed under FitLife Brands following its 2023 asset acquisition and strategic business repositioning.
MusclePharm (OTCMKTS:MSLP) & Hepion Pharmaceuticals (NASDAQ:HEPA) Critical Contrast
MusclePharm (OTCMKTS:MSLP) and Merck KGaA (OTCMKTS:MKGAF) Head-To-Head Analysis
MusclePharm Files For Uplisting IPO To Nasdaq
MusclePharm to Present at the LD Micro Invitational XII Conference
MusclePharm Corporation (MSLP) CEO Ryan Drexler on Q1 2022 Results - Earnings Call Transcript
MusclePharm to Announce Fourth Quarter and Full Year 2021 Financial Results on Thursday, April 14, 2022
MusclePharm Corporation (MSLP) CEO Ryan Drexler on Q3 2021 Results - Earnings Call Transcript
MusclePharm to Announce Third Quarter 2021 Financial Results on Monday, November 15, 2021
MusclePharm Announces Closing of $7.0 Million Senior Secured Notes Offering
MusclePharm Closes More Pre-Orders Reaching Pre-Production Sales Goal of $1 Million for MP Performance Energy Line Through Collective Distributors
MusclePharm's (MSLP) CEO Ryan Drexler on Q2 2021 Results - Earnings Call Transcript
MusclePharm Increases Sequential Sales in Second Quarter 2021 Despite Continued Industry Wide Supply Chain Challenges
MusclePharm Announces Colorado Distribution Partnership with New Age, Inc.
MusclePharm Closes Potential $7.3 Million Liability with IRS
MusclePharm Names 11th Largest Accounting Firm, Moss Adams, as Independent Auditor
MusclePharm Closes More Pre-Orders Bringing Pre-Production Sales Orders to Approximately $600,000
MusclePharm Closes $500,000 in Initial Orders for MP Performance Energy Line Through Collective Distributors
MusclePharm Appoints New Independent Board Member
MusclePharm Corporation's (MSLP) CEO Ryan Drexler on Q1 2021 Results - Earnings Call Transcript
MusclePharm Delivers Profitable First Quarter 2021 Despite Industry Wide Supply Shortages